Interferon-α2a reduces MRI disease activity in relapsing-remitting multiple sclerosis

Saved in:

Bibliographic Details
Published in:	Neurology Vol. 52; no. 5; pp. 1049 - 1056
Main Authors:	MYHR, K. M, RIISE, T, SMIEVOLL, A. I, VEDELER, C, NYLAND, H. I, LILLEAS, F. E. G, BEISKE, T. G, CELIUS, E. G, EDLAND, A, JENSEN, D, LARSEN, J. P, NILSEN, R, NORTVEDT, M. W
Format:	Journal Article
Language:	English
Published:	Hagerstown, MD Lippincott Williams & Wilkins 23-03-1999
Subjects:	Biological and medical sciences Immunomodulators Medical sciences Pharmacology. Drug treatments Human Nervous system diseases Multiple sclerosis Multicenter study Clinical form Nuclear magnetic resonance imaging Long term Inflammatory disease Immunomodulator Chemotherapy Randomization Treatment Central nervous system disease Double blind study Medical imagery Adult Evolution Subcutaneous administration
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	0028-3878 1526-632X
DOI:	10.1212/wnl.52.5.1049